Fia Navntoft
Leo Mavely
Leo Mavely is the CEO of Axio Biosolutions a medtech company focused on novel
biomaterials for advanced wound care and surgical solutions. Axiostat® its flagship product
which was developed to reduce the mortality due to traumatic bleeding from life threatening
injuries and is approved in over 45 countries and used by major armed forces globally. Their
more recent offering, Maxiocel is a 100% chitosan based advanced woundcare platform that
is CE marked and now used across Europe.
A bioengineer by qualification, Leo invented the core technology of Axio and is passionate
about building affordable healthcare products. Leo holds multiple patents and publications in
the field of novel biomaterials for medical tech applications.
Leo was featured in the list of 40 under 40 emerging business leaders by Fortune Magazine
consecutively in 2016, 2017, 2018 and 2019 and in the list of 35 under 35 entrepreneurs by
Entrepreneur magazine in 2020. He was the recipient of Silicon valley challenge 2014,
Anjani Mashelkar Inclusive Innovation Award 2013, CNBC Samsung Social Innovation
Award 2012 and was invited speaker at Indian Science congress 2010.
Axio has raised over $20mn in venture funding from Accel Partners, Ratan Tata’s UC-RNT
Fund, Omidyar network, Chiratate venture and TrueScale capital. Axio has its state of the art
R&D and manufacturing facility in India and is head quartered in Cambridge, USA.
Aaron Morales
Mallikarjun Choudhary
Samir Kumar
Samir is a managing director at M12, leading investments globally where artificial intelligence or machine learning is a key point of leverage.
He also stewards the fund’s Vanguard Bets investment category—startups aiming for breakthroughs that will result in generational shifts in the technology landscape. Samir’s other investment focuses include quantum computing, robotics, autonomous systems, transportation and silicon—especially for AI. Samir manages a team developing theses for new technology areas and oversees the fund’s technical and scientific advisory board.
Prior to joining M12, Samir was a senior director of business development and product management in Qualcomm’s corporate R&D division. There, he led early-stage product validation, partnerships, acquisitions, and strategy for embedded machine learning, computer vision and heterogeneous computing. Samir started his career at Microsoft, where he spent several years leading product management and product planning efforts for enterprise mobility before joining Palm and Samsung.
Samir is a regular conference speaker on his investment focus areas. He has served on or moderated panels of VCs and subject matter experts at LDV Vision Summit, tinyML Summit, and Cybersec&AI Connected.
Anda Sapardan
Ananya Chandra
Ananya is Managing Partner of Innopact - an early-stage investor in high-impact technology startups across emerging markets. She also leads Women Prosperity Lab, a startup ecosystem enabler backing the future of womentech.
Previously, Ananya co-headed Accelerating Growth of New India’s Innovations (AGNIi), the flagship innovation initiative of the Office of the Principal Scientific Adviser to the Government of India. Here, she collaborated with key national and international stakeholders to promote commercialization and scale-up of innovative technologies across India.
Prior to AGNIi, Ananya has been an entrepreneur. She was co-founder and COO of Just Move, an award-winning health-tech startup with marquee investors, that she led to exit in 2016. Ananya has also led the expansion of India’s largest womentech startup, Sheroes, into Southeast Asia.
Ananya started her career with international law firm Clifford Chance LLP in London, with stints in Singapore and Abu Dhabi. Ananya is an alumni of HEC Paris (Msc. In Innovation and Entrepreneurship), Stanford University's Institute for Innovation in Developing Economies and National Law School, Bangalore (B.A., LL.B) and has lived and worked in 8 countries.